These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26992147)

  • 21. Crystal structures of the ligand-binding domain of human peroxisome proliferator-activated receptor δ in complexes with phenylpropanoic acid derivatives and a pyridine carboxylic acid derivative.
    Oyama T; Takiguchi K; Miyachi H
    Acta Crystallogr F Struct Biol Commun; 2022 Feb; 78(Pt 2):81-87. PubMed ID: 35102897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential sensitivities of the vascular K(ATP) channel to various PPAR activators.
    Wang Y; Yu L; Cui N; Jin X; Zhu D; Jiang C
    Biochem Pharmacol; 2013 May; 85(10):1495-503. PubMed ID: 23500542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.
    Molnár F; Matilainen M; Carlberg C
    J Biol Chem; 2005 Jul; 280(28):26543-56. PubMed ID: 15888456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.
    Benetti E; Patel NS; Collino M
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):273-84. PubMed ID: 21696362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat.
    Kapoor A; Collino M; Castiglia S; Fantozzi R; Thiemermann C
    Shock; 2010 Aug; 34(2):117-24. PubMed ID: 19997057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain.
    Yu S; Levi L; Casadesus G; Kunos G; Noy N
    J Biol Chem; 2014 May; 289(18):12748-58. PubMed ID: 24644281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
    Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring conformational changes in peroxisome proliferator-activated receptor α by a genetically encoded photoamino acid, cross-linking, and mass spectrometry.
    Schwarz R; Tänzler D; Ihling CH; Müller MQ; Kölbel K; Sinz A
    J Med Chem; 2013 Jun; 56(11):4252-63. PubMed ID: 23639233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.
    Palomer X; Barroso E; Pizarro-Delgado J; Peña L; Botteri G; Zarei M; Aguilar D; Montori-Grau M; Vázquez-Carrera M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
    Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Regulation of PPARs through Post-Translational Modifications.
    Brunmeir R; Xu F
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
    Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB
    Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
    Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
    Bishop-Bailey D; Bystrom J
    Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harnessing the benefits of PPARβ/δ agonists.
    Mackenzie LS; Lione L
    Life Sci; 2013 Dec; 93(25-26):963-7. PubMed ID: 24184294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription.
    Kaddatz K; Adhikary T; Finkernagel F; Meissner W; Müller-Brüsselbach S; Müller R
    J Biol Chem; 2010 Sep; 285(38):29469-79. PubMed ID: 20595396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.